Matches 1 - 50 out of 336 1 2 3 4 5 6 7 >


Match Document Document Title
9028866 Methods and compositions for oral pharmaceutical therapy  
It now has been found that oral administration of pharmaceutical agents, including N-methylol transfer agents such as Taurolidine may be used to provide efficacious blood plasma concentration of...
9023386 Microspheres comprising nanocapsules containing a lipophilic drug  
The present invention provides microspheres comprising a plurality of nanocapsules accommodated in a gel forming polymer, the plurality of nanocapsules comprising an oil core carrying a non...
9023630 Bone cell delivery device  
Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to...
9011908 Progesterone solutions for increased bioavailability  
Fill materials for hydrophobic drugs, such as progesterone, and methods of making and using thereof are described herein. The fill material contains the hydrophobic drug dissolved in one or more...
9005944 Bone cell delivery device  
Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to...
8999296 Method of detecting bladder cancer  
Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient....
8999360 Compositions and methods for treating extracellular parasitic infections  
There is disclosed herein a composition for treating extracellular parasitic infections, the composition comprising one or more of the following combinations: at least one quinolone or...
8999383 Compositions of GnRH related compounds and processes of preparation  
The present invention provides compositions of GnRH related compounds that are suitable for oral administration, injectable administration and other forms of administration wherein the gelling...
8986723 Oil formulations comprising cylcopropene compounds  
A composition comprising (a) a non-aqueous pourable fluid, (b) droplets dispersed in said pourable fluid (a), wherein said droplets comprise (i) a non-aqueous continuous phase that is a solid or...
8980314 Enteric formulation of duloxetine and its core and preparation method  
An enteric formulation of duloxetine, its core and preparing method thereof are disclosed. The core comprises duloxetine or its salt and pharmaceutically acceptable excipients. The excipients...
8980320 Film coating agent for solid preparation, and solid preparation using same  
A film coating agent for a solid formulation includes a water-soluble cellulose derivative, swelling clay, a cationic surfactant, and a fatty acid, wherein mass ratio of the swelling clay to the...
8974822 Oral formulations of bipolar trans carotenoids  
The subject invention relates to a variety of formulations of bipolar trans carotenoids including pharmaceutical compositions for oral delivery of a bipolar trans carotenoid comprising i) a...
8962004 Encapsulated triazinyl sulfonylurea herbicide and methods of use  
The invention relates to compositions including an encapsulated triazinyl sulfonylurea. The invention further relates to methods for controlling weeds. The invention additionally provides methods...
8957053 Proliposomal testosterone formulations  
Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder...
8951558 Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer  
The invention relates to an aqueous medium containing an amino(meth)acrylate polymer or copolymer which is not soluble in dematerialised water, characterized in that the medium has a content of an...
8932628 Modified release formulations of a bupropion salt  
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of...
8900575 Compositions and methods for oxalate reduction  
The present invention comprises methods and compositions for the reduction of oxalate in humans. For example, the invention provides methods and compositions for the delivery of one or more...
8889180 Coated drug delivery formulations  
The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided. In...
8865190 Pharmaceutical compositions for the coordinated delivery of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
8858991 Delayed release oral pharmaceutical dosage forms comprising MGBG  
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time...
8852636 Pharmaceutical compositions for the coordinated delivery of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
8846100 Controlled dose drug delivery system  
A multiple pulsed dose drug delivery system for pharmaceutically active amphetamine salts, comprising a pharmaceutically active amphetamine salt covered with an immediate-release coating and a...
8840923 Slow-release pharmaceutical formulation and process for its preparation  
Slow-release excipients which comprise an association of at least one glycogen and at least one alginate with an alkaline-earth metal salt are useful for the preparation of slow-release...
8815284 Bioerodible sustained release drug delivery systems  
The present invention relates to sustained release drug delivery systems, medical devices incorporating said systems, and methods of use and manufacture thereof. The inventive systems feature...
8784886 Coating capsules with active pharmaceutical ingredients  
Pharmaceutical compositions in unit dose form comprising capsules containing one or more first active pharmaceutical ingredient in a pharmaceutically acceptable vehicle, coated with one or more...
8728520 Cross-linked alginate-polyalkylene glycol polymer coatings for encapsulation and methods of making the same  
A biocompatible capsule comprising a biological material encapsulated by a covalently stabilized coating and a method of making the same are disclosed. The biological material can be a material...
8697123 Medication on the basis of 3,3′-diindolylmethane (DIM) with high-bioavailability and its use in treatment of human hyperplastic and inflammatory diseases  
The invention relates to medicine and chemico-pharmaceutical industry. A medication for treating human hyperplastic and inflammatory diseases containing 3,3′-diindolylmethane as an active agent...
8691545 Bone semi-permeable device  
Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to...
8685446 Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients  
The invention relates to microcapsules, and a continuous micro-encapsulation water-in-oil-in-water microencapsulation process through in situ and interfacial polymerization of the emulsion. The...
8668932 Extended release venlafaxine formulation  
A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
8652516 Doxycycline formulations, and methods of treating rosacea  
The present invention is directed to a pharmaceutical composition in unit dose form for orally delivering doxycycline to a human, the pharmaceutical composition comprising: a capsule, wherein the...
8647645 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith  
The present invention is directed to immediate release film coating systems for use on oral dosage forms such as compressed tablets and other orally-ingestible substrates which have improved...
8609138 ω3 fatty acid compound preparation  
Provided is a compound preparation including at least one selected from the group consisting of ω3 polyunsaturated fatty acids and pharmaceutically acceptable salts and esters thereof and at least...
8609198 Pharmaceutical dose form with a patterned coating and method of making the same  
A method for producing a pharmaceutical dose form includes depositing a measured quantity of a first coating material on an external surface of the dose form in a patterned configuration. A...
8609139 Formulations for enhanced bioavailability of orally administered polar agents  
A composition is described having improved oral permeability of polar agents such as neuraminidase inhibitors. The composition includes one or more polar agents and one or more permeability...
8591920 Stable lipophilic emulsions for acrylic coating and method of making  
Emulsions of lipophiles such as glycerol monostearate which are compatible with acrylic copolymer emulsions are made stable by using an emulsion stabilizer such as polysorbate 80 in an amount by...
8586026 Bacterial diversity  
Use of one strain of Lactobacillus plantarum for the manufacture of a composition for increasing the diversity of the gastrointestinal tract by administration of said strain to an individual with...
8557285 Pharmaceutical compositions for the coordinated delivery of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
8501226 Coating method  
The present invention concerns a method for coating granules comprising mesalazine, with a coating mixture comprising two polymers, polymer I and polymer II; said polymer I being selected to allow...
8491929 Bioadhesive polymers  
Polymers and compositions, collectively “bioadhesive materials”, with improved bioadhesive properties have been developed. One or more compounds comprising: a) an aromatic moiety comprising two or...
8465769 Pharmaceutical composition with controlled active ingredient release for active ingredients with good solubility in water  
A pharmaceutical preparation comprising: a) a core with an active ingredient and with an organic acid and/or the salt of an organic acid; andb) a coating which envelops the core and which...
8455662 Formulations for benzimidazolyl pyridyl ethers  
Formulations are provided, comprising: a compound of Formula I, a pharmaceutically acceptable salt thereof, or a mixture of any two or more thereof; and an ingredient selected from a hydrophilic...
8449878 Prebiotic formulations for use with probiotics to increase probiotic growth rate and activity  
Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate...
8444967 Treatment including prebiotic composition for use with probiotics  
A method is described to treat diarrhea, vaginal yeast infections, constipation, heartburn, bloating, indigestion, flatulence or poor nutrient absorption, by administering a formulation of...
8414917 Chewable capsule and production method thereof  
This chewable capsule has an encapsulating shell and a filling contained within the encapsulating shell, in which outer diameter of the above encapsulating shell ranges from 14 mm to 25 mm, and...
8414905 Film coating compositions based on polyvinyl alcohol-polyether graft copolymer/polyvinyl alcohol combinations with an improved moisture barrier effect  
Film coating compositions based on a co-processed mixture of a polyvinyl alcohol-polyether graft polymer and polyvinyl alcohol (component A), a N-vinylpyrrolidone-vinyl acetate copolymer...
8394407 Delayed release tablet with defined core geometry  
A tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85...
8388984 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules  
Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the...
8389005 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance  
Alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administration to a mammal of...
8367078 Kinase inhibitor compounds  
The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating disorders,...

Matches 1 - 50 out of 336 1 2 3 4 5 6 7 >